The expression of IL4I1, KYNA, KMO, IDO1, TDO2, 5-HT, and TPH1 is notably increased in CRC tissues, with strong correlations observed between these TRP metabolites and various clinical features [61–65, 84]. The gene discussed is IDO1; the disease is colorectal carcinoma.